Cargando…

Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results

BACKGROUND: Uterine fibroid embolisation (UFE) is an established treatment method for symptomatic uterine myomas. This study evaluates the efficacy of UFE using objective magnetic resonance imaging (MRI) data for size and perfusion analysis as well as patient questionnaires assessing fibroid-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadick, Maliha, Hofmann, Leonie, Weiß, Christel, Tuschy, Benjamin, Schönberg, Stefan O., Zöllner, Frank G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724260/
https://www.ncbi.nlm.nih.gov/pubmed/36471287
http://dx.doi.org/10.1186/s12880-022-00926-y
_version_ 1784844371635470336
author Sadick, Maliha
Hofmann, Leonie
Weiß, Christel
Tuschy, Benjamin
Schönberg, Stefan O.
Zöllner, Frank G.
author_facet Sadick, Maliha
Hofmann, Leonie
Weiß, Christel
Tuschy, Benjamin
Schönberg, Stefan O.
Zöllner, Frank G.
author_sort Sadick, Maliha
collection PubMed
description BACKGROUND: Uterine fibroid embolisation (UFE) is an established treatment method for symptomatic uterine myomas. This study evaluates the efficacy of UFE using objective magnetic resonance imaging (MRI) data for size and perfusion analysis as well as patient questionnaires assessing fibroid-related symptoms. METHOD: Patients underwent MR-Angiography before UFE and 4 days, 6 and 12 months after the procedure. The images were evaluated using dedicated software. Patient questionnaires were completed before UFE and at 12 months follow-up, focussing on the embolization procedure and symptoms associated with uterine fibroids. Statistical analysis of the questionnaires was performed using paired sample t-test and Wilcoxon signed rank test, while Kruskal–Wallis test and Friedman test were applied for MRI-analysis. RESULTS: Eleven women were included. There was a significant reduction in fibroid-related symptoms. The volume reduction after 12 months was significant in both, uterus and myomas, after an initial increase in uterine volume at the first post-interventional MRI. The perfusion analysis showed that blood flow to the fibroids could be significantly reduced up to 12 months after UFE while uterine tissue was not affected. CONCLUSION: This study shows that uterine fibroid embolisation induces a significant long-term decrease in myoma size and perfusion while healthy uterine tissue remains unaffected. Fibroid-related symptoms are reduced for the sake of improved quality of life.
format Online
Article
Text
id pubmed-9724260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97242602022-12-07 Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results Sadick, Maliha Hofmann, Leonie Weiß, Christel Tuschy, Benjamin Schönberg, Stefan O. Zöllner, Frank G. BMC Med Imaging Research BACKGROUND: Uterine fibroid embolisation (UFE) is an established treatment method for symptomatic uterine myomas. This study evaluates the efficacy of UFE using objective magnetic resonance imaging (MRI) data for size and perfusion analysis as well as patient questionnaires assessing fibroid-related symptoms. METHOD: Patients underwent MR-Angiography before UFE and 4 days, 6 and 12 months after the procedure. The images were evaluated using dedicated software. Patient questionnaires were completed before UFE and at 12 months follow-up, focussing on the embolization procedure and symptoms associated with uterine fibroids. Statistical analysis of the questionnaires was performed using paired sample t-test and Wilcoxon signed rank test, while Kruskal–Wallis test and Friedman test were applied for MRI-analysis. RESULTS: Eleven women were included. There was a significant reduction in fibroid-related symptoms. The volume reduction after 12 months was significant in both, uterus and myomas, after an initial increase in uterine volume at the first post-interventional MRI. The perfusion analysis showed that blood flow to the fibroids could be significantly reduced up to 12 months after UFE while uterine tissue was not affected. CONCLUSION: This study shows that uterine fibroid embolisation induces a significant long-term decrease in myoma size and perfusion while healthy uterine tissue remains unaffected. Fibroid-related symptoms are reduced for the sake of improved quality of life. BioMed Central 2022-12-05 /pmc/articles/PMC9724260/ /pubmed/36471287 http://dx.doi.org/10.1186/s12880-022-00926-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Sadick, Maliha
Hofmann, Leonie
Weiß, Christel
Tuschy, Benjamin
Schönberg, Stefan O.
Zöllner, Frank G.
Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title_full Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title_fullStr Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title_full_unstemmed Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title_short Long-term evaluation of uterine fibroid embolisation using MRI perfusion parameters and patient questionnaires: preliminary results
title_sort long-term evaluation of uterine fibroid embolisation using mri perfusion parameters and patient questionnaires: preliminary results
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724260/
https://www.ncbi.nlm.nih.gov/pubmed/36471287
http://dx.doi.org/10.1186/s12880-022-00926-y
work_keys_str_mv AT sadickmaliha longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults
AT hofmannleonie longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults
AT weißchristel longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults
AT tuschybenjamin longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults
AT schonbergstefano longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults
AT zollnerfrankg longtermevaluationofuterinefibroidembolisationusingmriperfusionparametersandpatientquestionnairespreliminaryresults